N-Site New Guidance Notes - March 2021

New Deals guidance from PharmaVentures

GNX9: Transactions – Good Practice Part I

Having advised multiple major pharmaceutical companies on their manufacturing divestment strategy for more than 40 of their manufacturing operations globally, PharmaVentures share good practice guidance in the first of 2 guidance notes covering the main stages of the transactions process: pre-marketing; marketing; dataroom preparation and curation; management presentation and site tour; and negotiation. Read more>>

GNX10: Transactions – Good Practice Part II  Read more>>

New Executive Search and Organisational Strategy guidance from Virdis Group

GNES8: The Importance of Learning Agility

Why do organisations need professionals with learning agility? The world in 2021 looks different from the one we left behind. There have been substantial changes to many aspects of our lives: from the way we work, to where we work, from the technology we use to connect, to the very notion of social connection. Read more>>

New Legal guidance from Taylor Wessing

GNL35: What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies

The UK left the EU on 31 January 2020 but has been operating “as if” within the EU under a transition period ending on 31 December 2020. From 1 January 2021 the EU and the UK operate as separate sovereign jurisdictions subject to agreements on individual matters. Read more>>

GNL36: Placing medical devices on the UK market after the end of Brexit transition

From 1 January 2021 a new regime will apply to medical devices placed on the market in the UK. New medical device regulations for the UK were published in 2019. Read more>>

New Market Access and Pricing guidance from MAP BioPharma

GNMA7: Impact of Brexit on the regulatory approval process for medicines in the UK

The end of the transition period marks the end of the Medicines and Healthcare products Regulatory Agency (MHRA)’s participation in the European Medicines Agency (EMA)’s centralised procedure.  Read more>>

GNT68: Making Tax Digital (MTD) for VAT (Phase II)

This Guidance Note gives an overview of the MTD for VAT Phase II requirements that come into force on 1 April 2021 and describes the implications of Digital Linking and the steps a company needs to take to ensure compliance. Read more>> 

GNT69: Making Tax Digital for Corporation Tax (MTD for CT)

This Guidance Note gives an overview of MTD for CT and describes the changes that this forthcoming legislation will create. It provides advice on how companies will need to react to meet the new regulations in time. Read more>> 

GNT70: Working from Home (in the UK and abroad) - Common Tax Concerns

Employers can (subject to conditions) and without incurring income tax and NICs, provide employees with: equipment to help them work from home and money to cover additional working from home expenses (at the flat rate of £6 per week, or the actual amounts incurred). Read more>>